Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of incorporating genetic variants for the early detection of prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2009

Nam Robert K, Zhang William W, Trachtenberg John, Seth Arun, Klotz Laurence H, Stanimirovic Aleksandra, Punnen Sanoj, Venkateswaran Vasundara, Toi Ants, Loblaw D Andrew, Sugar Linda, Siminovitch Katherine A, Narod Steven A

Abstract excerpt

PURPOSE: Several single nucleotide polymorphisms (SNP) have been associated with the risk of prostate cancer. The clinical utility of using SNPs in the early detection of prostate cancer has not been evaluated. EXPERIMENTAL DESIGN: We examined a panel of 25 SNPs from candidate genes and chromosomal regions in 3,004 unselected men who were screened for prostate cancer using serum prostate-specific antigen (PSA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Area Under Curve

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Early Diagnosis

Share to Odds Ratio

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to ROC Curve

Source

Identifiers

PMID: 19223501
DOI: 10.1158/1078-0432.CCR-08-1593

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of incorporating genetic variants for the early detection of prostate cancer.PMID 19223501Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

Early detection of prostate cancer with emphasis on genetic markers.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.Semantic proximity Read ↗

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Semantic proximity Read ↗

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.Semantic proximity Read ↗

Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.Semantic proximity Read ↗

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.Semantic proximity Read ↗

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).Semantic proximity Read ↗

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.